Novamox CV Drop is a prescription antibiotic suspension containing 80mg of Amoxycillin and 11.4mg of Clavulanic Acid per 5mL. This combination medication is indicated for the treatment of various bacterial infections in pediatric patients. The antibacterial action of Amoxycillin, a semi-synthetic penicillin, is augmented by Clavulanic Acid, which inhibits beta-lactamases, thereby enhancing the effectiveness against beta-lactamase-producing strains. The administration of Novamox CV Drop should be under the supervision of a healthcare professional, and the full course of treatment must be completed for optimal efficacy. It is essential to adhere to the prescribed dosage regimen and monitor for any adverse reactions or signs of treatment failure.